Alloimmunisation rate of patients on Daratumumab : A retrospective cohort study of patients in England-Reference-Cited by-同舟云学术

Alloimmunisation rate of patients on Daratumumab : A retrospective cohort study of patients in England

Published:2021-08-17 Issue:6 Volume:31 Page:474-480
ISSN:0958-7578
Container-title:Transfusion Medicine
language:en
Short-container-title:Transfusion Medicine

Author:

Bullock Tom¹^ORCID,Foster Amie²,Clinkard Bryony³

Affiliation:

1. Red Cell Immunohaematology, NHSBT, Filton Centre Bristol UK

2. Red Cell Immunohaematology, NHSBT, Newcastle Centre Newcastle UK

3. Clinical Audit, NHSBT, Filton Centre Bristol UK

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tme.12808

Reference25 articles.

1. NICE guidance on daratumumab with bortezomib and dexamethasone for previously treated multiple myeloma

2. NICE Technology Appraisal Guidance [TA510].Daratumumab monotherapy for treating relapsed and refractory multiple myeloma.https://www.nice.org.uk/guidance/ta510. Accessed May 21 2020.

3. British Society for Haematology.Daratumumab combination therapy approved for relapsed multiple myeloma.https://b-s-h.org.uk/about-us/news/daratumumab-combination-therapy-approved-for-relapsed-multiple-myeloma/. Accessed May 21 2020.

4. British National Formulary (BNF).Daratumumab.https://bnf.nice.org.uk/drug/daratumumab.html#drugAction. Accessed May 21 2020.

5. Interference of New Drugs with Compatibility Testing for Blood Transfusion

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Valutazione di un metodo commerciale basato sull'utilizzo del CD38 solubile per mitigare l'interferenza del daratumumab sui test pre-trasfusionali;La Rivista Italiana della Medicina di Laboratorio;2024-09

2. Interference of Monoclonal Antibody Therapy in Transfusion: An Update;Hemato;2024-07-02

3. Risk of new alloimmunization in patients on anti-CD38 treatment using tube LISS-IAT method;Transfusion and Apheresis Science;2024-04

4. Daratumumab interference with blood‐compatibility testing after autologous stem cell transplantation;Transfusion Medicine;2023-01-05

5. Intricacies of GATA-ca, continued;Haematologica;2022-03-03